• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Verification of a new hypothesis that cancer stem cells induce immune cell senescence-related immunosuppression and exert tumorigenicity

Research Project

Project/Area Number 16K18408
Research Category

Grant-in-Aid for Young Scientists (B)

Allocation TypeMulti-year Fund
Research Field Tumor biology
Research InstitutionHokkaido University

Principal Investigator

WADA HARUKA  北海道大学, 遺伝子病制御研究所, 講師 (70392181)

Project Period (FY) 2016-04-01 – 2018-03-31
Project Status Completed (Fiscal Year 2017)
Budget Amount *help
¥4,160,000 (Direct Cost: ¥3,200,000、Indirect Cost: ¥960,000)
Fiscal Year 2017: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
Fiscal Year 2016: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
Keywordsがん幹細胞 / 細胞老化 / 免疫抑制 / 造腫瘍細胞 / マクロファージ / 炎症 / 老化 / 腫瘍免疫 / 抗腫瘍免疫応答 / 造腫瘍能 / 免疫細胞
Outline of Final Research Achievements

In this study, we found that cancer stem cells itself produce inflammatory cytokines, TICIF-1. TICIF-1 induced cellular senescence-like phenotypes and immunosuppressive phenotype into the surrounding macrophages. Commonly, SASP is known as inflammatory phenomena, however, our results suggested that senescence-associated phenotypes are different depending on cell types.
TICIF-1 is known as one of the SASP factors and it is suggested the correlation with tumorigenesis. On this point, Our results suggested that TICIF-1 induce macrophages into immunosuppressive phenotype, eventually, it contributes to tumorigenesis in immunocompetent animals.

Report

(3 results)
  • 2017 Annual Research Report   Final Research Report ( PDF )
  • 2016 Research-status Report
  • Research Products

    (23 results)

All 2018 2017 2016 Other

All Journal Article (6 results) (of which Int'l Joint Research: 2 results,  Peer Reviewed: 6 results,  Open Access: 4 results,  Acknowledgement Compliant: 1 results) Presentation (13 results) (of which Int'l Joint Research: 4 results,  Invited: 2 results) Book (2 results) Remarks (2 results)

  • [Journal Article] High co-expression of IL-34 and M-CSF correlates with tumor progression and poor survival in lung cancers.2018

    • Author(s)
      Baghdadi M, Endo H, Takano A, Ishikawa K, Kameda Y, Wada H, Miyagi Y, Yokose T, Ito H, Nakayama H, Daigo Y, Suzuki N, Seino KI.
    • Journal Title

      Sci Rep.

      Volume: 11;8(1) Issue: 1 Pages: 418-427

    • DOI

      10.1038/s41598-017-18796-8

    • NAID

      120006414003

    • Related Report
      2017 Annual Research Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Enhanced IL-34 expression in Nivolumab-resistant metastatic melanoma.2018

    • Author(s)
      Han N, Baghdadi M, Ishikawa K
    • Journal Title

      Inflammation and Regeneration

      Volume: 5 Issue: 1 Pages: 3-3

    • DOI

      10.1186/s41232-018-0060-2

    • Related Report
      2017 Annual Research Report
    • Peer Reviewed / Open Access / Int'l Joint Research
  • [Journal Article] Interleukin 34, from pathogenesis to clinical applications2017

    • Author(s)
      Baghdadi Muhammad、Endo Hiraku、Tanaka Yoshino、Wada Haruka、Seino Ken-ichiro
    • Journal Title

      Cytokine

      Volume: 99 Pages: 139-147

    • DOI

      10.1016/j.cyto.2017.08.020

    • Related Report
      2017 Annual Research Report
    • Peer Reviewed / Open Access
  • [Journal Article] Identification of a Highly Immunogenic Mouse Breast Cancer Sub Cell Line, 4T1-S.2016

    • Author(s)
      Abe H, Wada H, Baghdadi M, Nakanishi S, Usui Y, Tsuchikawa T, Shichinohe T, Hirano S and Seino K
    • Journal Title

      Human Cell

      Volume: 29 Pages: 58-66

    • NAID

      120006024339

    • Related Report
      2016 Research-status Report
    • Peer Reviewed
  • [Journal Article] Transcriptional regulator Bhlhe40 works as a cofactor of T-bet in the regulation of IFN-γ production in iNKT cell2016

    • Author(s)
      Kanda M, Yamanaka H, Kojo S, Usui Y, Honda H, Sotomaru Y, Harada M, Taniguchi M, Suzuki N, Atsumi T, Wada H, Bagdadi M, Seino, K
    • Journal Title

      Proceedings of the National Academy of Sciences of the USA

      Volume: 14: 113(24) Issue: 24

    • DOI

      10.1073/pnas.1604178113

    • Related Report
      2016 Research-status Report
    • Peer Reviewed / Open Access
  • [Journal Article] Chemotherapy-induced IL-34 enhances immunosuppression by tumor-associated macrophages and mediates survival of chemoresistant lung cancer cells2016

    • Author(s)
      Baghdad M, Wada H, Nakanishi S, Abe H, Han N, Putra WE, Endo D, Watari H, Sakuragi N, Hida Y, Kaga K, Miyagi Y, Yokose T, Takano A, Daigo Y, Seino K.
    • Journal Title

      Cancer res.

      Volume: 76 Pages: 6030-6042

    • NAID

      120006347198

    • Related Report
      2016 Research-status Report
    • Peer Reviewed / Acknowledgement Compliant
  • [Presentation] Immunological features of tumor cells defines tumor-initiating capacity in immunocompetent animal2018

    • Author(s)
      Haruka Wada, Muhammad Baghdadi and Ken-ichiro Seino
    • Organizer
      第15回 日本免疫治療学研究会学術集会
    • Related Report
      2017 Annual Research Report
  • [Presentation] IL34-modified tumor-associated macrophages suppress anti-tumor T cell response at the local tumor microenvironment2017

    • Author(s)
      Baghdadi M, Endo H, Ishikawa K, Wada H, Seino K
    • Organizer
      7th International workshop of Kyoto T cell conference
    • Place of Presentation
      京都大学、京都市
    • Year and Date
      2017-03-13
    • Related Report
      2016 Research-status Report
    • Int'l Joint Research
  • [Presentation] IL34-modified tumor-associated macrophages suppress anti-tumor T cell response at the local tumor microenvironment2017

    • Author(s)
      Muhammad Baghdadi, Hiraku Endo, Kozo Ishikawa, Haruka Wada, Kenichiro Seino
    • Organizer
      7th International Wrokshop of Kyoto T cell conference
    • Related Report
      2017 Annual Research Report
    • Int'l Joint Research
  • [Presentation] A novel pathogenic role of IL34 in modifying the immunosuppressive features of chemotherapy-treated tumor microenvironment2017

    • Author(s)
      Baghdadi Muhammad、遠藤拓、石川浩三、和田はるか、清野研一郎
    • Organizer
      第14回日本免疫治療学研究会学術集会
    • Related Report
      2017 Annual Research Report 2016 Research-status Report
  • [Presentation] Immunological features of tumor initiating cells2017

    • Author(s)
      Haruka Wada, Muhammad Baghdadi, Ken-ichiro Seino
    • Organizer
      第21回日本がん免疫学会
    • Related Report
      2017 Annual Research Report
  • [Presentation] Deficiency of calcium-independent phospholipase A2beta represents a sensitized state for hepatocellular carcinoma in aged mice housed in infected facility2017

    • Author(s)
      Wang Wei, Johannes Inhoffen, Hongying Gan-Schreier, Sabine Tuma-Kellner, Beate Straub, Haruka Wada, Kenichiro Seino, Gerhard Liebisch, Wolfgang Stremmel, Walee Chamulitrat
    • Organizer
      International Liver Congress; 2017 - 52st annual meeting of the European Association for the Study of the Liver
    • Related Report
      2017 Annual Research Report
    • Int'l Joint Research
  • [Presentation] Dying but not dead cancer cells exert the effect of cell-based cancer vaccine2017

    • Author(s)
      Yoshino Tanaka, Haruka Wada, Muhammad Baghdadi, Ken-ichiro Seino
    • Organizer
      第46回日本免疫学会学術集会
    • Related Report
      2017 Annual Research Report
  • [Presentation] Tumor initiating cell in immunocompetent animal defined by immunological features2017

    • Author(s)
      Haruka Wada, Muhammad Baghdadi and Ken-ichiro Seino
    • Organizer
      第46回日本免疫学会学術集会
    • Related Report
      2017 Annual Research Report
  • [Presentation] iPS細胞を用いた未来医療2017

    • Author(s)
      和田はるか
    • Organizer
      第七回北海道免疫疾患談話会
    • Related Report
      2017 Annual Research Report
    • Invited
  • [Presentation] Tumor initiating cell in immunocompetent animal defined by immunological features2017

    • Author(s)
      Haruka Wada, Baghdadi Muhammad, Ken-ichiro Seino
    • Organizer
      中国免疫学会第十二届全国免疫学学術大会
    • Related Report
      2017 Annual Research Report
    • Int'l Joint Research / Invited
  • [Presentation] Identification of authentic tumor initiating cells in immunocompetent individuals2016

    • Author(s)
      Wada H, Baghdadi M, Seino K.
    • Organizer
      第45回 日本免疫学会
    • Place of Presentation
      沖縄コンベンションセンター、那覇市
    • Year and Date
      2016-12-05
    • Related Report
      2016 Research-status Report
  • [Presentation] A novel pathogenic role of interleukin-34 in cancer chemoresistance2016

    • Author(s)
      Baghdadi M, Ishikawa K, Wada H, Seino K
    • Organizer
      第45回 日本免疫学会
    • Place of Presentation
      沖縄コンベンションセンター、那覇市
    • Year and Date
      2016-12-05
    • Related Report
      2016 Research-status Report
  • [Presentation] 抗がん剤負荷によりがん細胞が産生するIL-34の腫瘍微小環境における役割2016

    • Author(s)
      和田はるか、Muhammad Baghdadi、清野研一郎
    • Organizer
      第26回Kyoto T cell conference
    • Place of Presentation
      延暦寺会館、大津市
    • Year and Date
      2016-05-20
    • Related Report
      2016 Research-status Report
  • [Book] IL34と腫瘍(臨床免疫・アレルギー科)2017

    • Author(s)
      ムハンマド・バグダーディー、 遠藤拓、和田はるか、清野研一郎
    • Total Pages
      5
    • Publisher
      科学評論社
    • Related Report
      2017 Annual Research Report
  • [Book] 多能性幹細胞を用いた免疫寛容誘導(移植)2017

    • Author(s)
      大塚亮、和田はるか、ムハンマド・バグダーディー、辻飛雄馬、清野研一郎
    • Total Pages
      6
    • Publisher
      日本移植学会
    • Related Report
      2017 Annual Research Report
  • [Remarks] 北海道大学遺伝子病制御研究所免疫生物分野

    • URL

      https://seinolab.wixsite.com/seinolab/home-1

    • Related Report
      2017 Annual Research Report
  • [Remarks] 北海道大学遺伝子病制御研究所免疫生物分野

    • URL

      http://www.igm.hokudai.ac.jp/Immunobiology-Web/Home.html

    • Related Report
      2016 Research-status Report

URL: 

Published: 2016-04-21   Modified: 2024-12-25  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi